CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-15 | Albright Charles EVP/Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 34,907 |
| 2020-12-15 | Albright Charles EVP/Chief Scientific Officer | Sale | −5,776 | $62.74 | $362K | 29,131 |
| 2020-12-15 | Albright Charles EVP/Chief Scientific Officer | Sale | −4,024 | $63.84 | $257K | 25,107 |
| 2020-12-15 | Albright Charles EVP/Chief Scientific Officer | Sale | −200 | $64.39 | $13K | 24,907 |
| 2020-12-15 | Albright Charles EVP/Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 145,000 | ||
| 2020-12-09 | Albright Charles EVP/Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 34,907 |
| 2020-12-09 | Albright Charles EVP/Chief Scientific Officer | Sale | −10,000 | $45.00 | $450K | 24,907 |
| 2020-12-09 | Albright Charles EVP/Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 155,000 | ||
| 2020-12-07 | Albright Charles EVP/Chief Scientific Officer | Option exercise | +20,000 | $16.51 | $330K | 44,907 |
| 2020-12-07 | Albright Charles EVP/Chief Scientific Officer | Sale | −20,000 | $40.02 | $800K | 24,907 |
| 2020-12-07 | Albright Charles EVP/Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −20,000 | 165,000 | ||
| 2020-11-09 | Albright Charles EVP/Chief Scientific Officer | Sale | −228 | $31.21 | $7K | 24,907 |
| 2020-10-15 | Albright Charles EVP/Chief Scientific Officer | Sale | −3,000 | $31.39 | $94K | 25,135 |
| 2020-08-17 | Albright Charles EVP/Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 38,135 |
| 2020-08-17 | Albright Charles EVP/Chief Scientific Officer | Sale | −10,000 | $35.29 | $353K | 28,135 |
| 2020-08-17 | Albright Charles EVP/Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 185,000 | ||
| 2020-08-07 | Albright Charles EVP/Chief Scientific Officer | Sale | −238 | $34.99 | $8K | 28,135 |
| 2020-08-06 | Albright Charles EVP/Chief Scientific Officer | Option exercise | +10,000 | $16.51 | $165K | 38,373 |
| 2020-08-06 | Albright Charles EVP/Chief Scientific Officer | Sale | −10,000 | $37.47 | $375K | 28,373 |
| 2020-08-06 | Albright Charles EVP/Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 195,000 |
Page 1 of 2 · 40 trades